Stay updated on PV-10 with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PV-10 with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Removed the related topics entries for 'Melanoma' and 'MedlinePlus Genetics', reducing cross-links to related content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-07T00:57:37.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Melanoma-related topics and state-level location entries were added. Several state-specific location pages were removed and the revision version updated to v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-23T21:08:12.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Deleted the 'Melanoma' topic and the 'MedlinePlus Genetics' related topic from the study page. This removes topic tags that previously connected the page to melanoma-related content and genetics resources.
    Difference
    0.2%
    Check dated 2025-12-09T14:27:08.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Record history now includes last known status and verification notes, and lists sponsor organization Provectus Biopharmaceuticals, Inc. along with related topics like MedlinePlus Genetics.
    Difference
    0.6%
    Check dated 2025-12-02T14:23:55.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed. This update appears to be metadata only and does not change study details.
    Difference
    0.1%
    Check dated 2025-11-25T10:42:32.000Z thumbnail image
  8. Check
    54 days ago
    Change Detected
    Summary
    - Removed the government funding status disclaimer that warned of possible delays and indicated where to find operating-status updates (cc.nih.gov; opm.gov). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:54:22.000Z thumbnail image

Stay in the know with updates to PV-10 with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.